NUV-1511 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

WSP Global raises Arcadis takeover offer to €51.50 as engineering consolidation accelerates

Wall Street welcomes Repligen’s $1.5bn BioLife deal, but integration now matters

Popular’s CEO is retiring after 14 months. Why investors should watch the CFO taking over

Renishaw plc (LSE: RSW) beats upgraded guidance with £815m full-year revenue

Innovative Cancer Treatment on the Horizon: Nuvation Bio's NUV-1511 Enters Clinical Trials

Read More

Pharma Industry News

Nuvation Bio receives FDA clearance for NUV-1511 IND in advanced solid tumors

In a significant stride for cancer treatment, Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company dedicated to addressing…

byPallavi Madhiraju

January 9, 2024

web analytics